Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Teva Pharmaceuticals Australia, Pty. Ltd. has implemented BLI’s Beacon platform in their antibody discovery programs. The Beacon platform is capable of screening thousands of antibody producing cells in less than a day. Cell characterizations […]
Empire Genomics announced today that it has entered into a new strategic partnership with KromaTiD to provide a comprehensive offering that helps researchers and clinicians better understand the genomic abnormalities of cancer patients. Empire Genomics CEO Anthony Johnson stated “KromaTiD’s Pinpoint FISH probes are a perfect complement to our existing FISH probe portfolio, allowing us […]
Customer Solutions Center will train up to 1,000 people a year in latest genomics technologies PARIS — Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris. The leading-edge customer training center will offer demonstrations, instruction, and education in the latest genomics technologies from Illumina for up to 1,000 scientists a […]
Tel Aviv Sourasky Medical Center and NRGene research exploring protection again neurodegenerative disease Tel Aviv & Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, has partnered with the Genetic Institute of Tel Aviv Sourasky Medical Center (TASMC) to perform genomic analysis of Parkinson’s disease (PD). “Our collaboration with NRGene and […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology. Heikki Lanckriet, CEO and CSO of SYGNIS AG, commented: “We are […]
Paris, France, and London, UK: Today, Biomillenia, the developer of Smart Microbes™, announced its collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) for use of QIAGEN’Ss Microbial Genomics Pro Suite to generate next-generation sequence data on microbes identified using Biomillenia’s proprietary microbe-on-a-chip technology. Biomillenia’s approach can identify strains of microbes previously deemed unculturable, and do so […]
Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas – and use as a core assay MINNEAPOLIS — Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000 publications and increasing to an average of more than one publication per […]
Accelerates growth in cell analysis, new technology and market development PEARLAND, Texas–Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb. Toronto-based Eventi Capital Partners Inc. […]
Latest version of Genedata’s enterprise platform enables innovation in cell line engineering, clone selection and biosafety assessment. Basel, Switzerland Genedata, a leading provider of advanced software solutions for R&D, today announced the global release of Genedata Selector 5, the latest version of its innovative enterprise software solution for genome management and analysis. The platform delivers […]
MADISON, WI USA Promega Corporation’s new NanoBRET™ Target Engagement (TE) Intracellular Kinase Assay is the first assay to quantify inhibitor drug binding to kinase proteins inside live human cells, as demonstrated in the recent Cell Chemical Biology article, “Quantitative, Wide-spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement.” In collaboration […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
